These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A new drug-screening procedure for photosensitizing agents used in photodynamic therapy for CNV. Lange N; Ballini JP; Wagnieres G; van den Bergh H Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):38-46. PubMed ID: 11133846 [TBL] [Abstract][Full Text] [Related]
5. Photodynamic-induced vascular damage of the chick chorioallantoic membrane model using perylenequinones. Chin W; Lau W; Lay SL; Wei KK; Olivo M Int J Oncol; 2004 Oct; 25(4):887-91. PubMed ID: 15375536 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo. Hua Z; Gibson SL; Foster TH; Hilf R Cancer Res; 1995 Apr; 55(8):1723-31. PubMed ID: 7712481 [TBL] [Abstract][Full Text] [Related]
7. Encapsulation of porphyrins and chlorins in biodegradable nanoparticles: the effect of dye lipophilicity on the extravasation and the photothrombic activity. A comparative study. Pegaz B; Debefve E; Borle F; Ballini JP; van den Bergh H; Kouakou-Konan YN J Photochem Photobiol B; 2005 Jul; 80(1):19-27. PubMed ID: 15963434 [TBL] [Abstract][Full Text] [Related]
8. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts. Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222 [TBL] [Abstract][Full Text] [Related]
9. Evidence for a bystander role of neutrophils in the response to systemic 5-aminolevulinic acid-based photodynamic therapy. de Bruijn HS; Sluiter W; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ Photodermatol Photoimmunol Photomed; 2006 Oct; 22(5):238-46. PubMed ID: 16948825 [TBL] [Abstract][Full Text] [Related]
10. In vivo damage to chorioallantoic membrane blood vessels by porphycene-induced photodynamic therapy. Gottfried V; Davidi R; Averguj C; Kimel S J Photochem Photobiol B; 1995 Oct; 30(2-3):115-21. PubMed ID: 8558365 [TBL] [Abstract][Full Text] [Related]
11. Demonstration of synergistic effects of hyperthermia and photodynamic therapy using the chick chorioallantoic membrane model. Kimel S; Svaasand LO; Hammer-Wilson M; Gottfried V; Cheng S; Svaasand E; Berns MW Lasers Surg Med; 1992; 12(4):432-40. PubMed ID: 1379665 [TBL] [Abstract][Full Text] [Related]
12. In vivo fluence rate and fractionation effects on tumor response and photobleaching: photodynamic therapy with two photosensitizers in an orthotopic rat tumor model. Iinuma S; Schomacker KT; Wagnieres G; Rajadhyaksha M; Bamberg M; Momma T; Hasan T Cancer Res; 1999 Dec; 59(24):6164-70. PubMed ID: 10626808 [TBL] [Abstract][Full Text] [Related]
13. Improved photodynamic activity of porphyrin loaded into nanoparticles: an in vivo evaluation using chick embryos. Vargas A; Pegaz B; Debefve E; Konan-Kouakou Y; Lange N; Ballini JP; van den Bergh H; Gurny R; Delie F Int J Pharm; 2004 Nov; 286(1-2):131-45. PubMed ID: 15501010 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of the photosensitizers aminolevulinic acid and aminolevulinic acid hexylester in oro-facial tumors embedded in the chorioallantois membrane of a hen's egg. Hoppenheit C; Hüttenberger D; Foth HJ; Spitzer WJ; Reichert TE; Müller-Richter UD Cancer Biother Radiopharm; 2006 Dec; 21(6):569-78. PubMed ID: 17257072 [TBL] [Abstract][Full Text] [Related]
15. In vivo photodynamic therapy with the new near-IR absorbing water soluble photosensitizer lutetium texaphyrin and a high intensity pulsed light delivery system. Kostenich G; Orenstein A; Roitman L; Malik Z; Ehrenberg B J Photochem Photobiol B; 1997 May; 39(1):36-42. PubMed ID: 9210320 [TBL] [Abstract][Full Text] [Related]
16. Protoporphyrin IX-accumulation in human tumor cells following topical ALA- and h-ALA-application in vivo. Zenzen V; Zankl H Cancer Lett; 2003 Dec; 202(1):35-42. PubMed ID: 14643024 [TBL] [Abstract][Full Text] [Related]
17. Photothrombic activity of m-THPC-loaded liposomal formulations: pre-clinical assessment on chick chorioallantoic membrane model. Pegaz B; Debefve E; Ballini JP; Wagnières G; Spaniol S; Albrecht V; Scheglmann DV; Nifantiev NE; van den Bergh H; Konan-Kouakou YN Eur J Pharm Sci; 2006 May; 28(1-2):134-40. PubMed ID: 16504490 [TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacokinetics of the PDT photosensitizers porfimer sodium (Photofrin), 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (Photochlor) and 5-ALA-induced protoporphyrin IX. Bellnier DA; Greco WR; Loewen GM; Nava H; Oseroff AR; Dougherty TJ Lasers Surg Med; 2006 Jun; 38(5):439-44. PubMed ID: 16634075 [TBL] [Abstract][Full Text] [Related]
19. Combined photodynamic and photothermal induced injury enhances damage to in vivo model blood vessels. Kelly KM; Kimel S; Smith T; Stacy A; Hammer-Wilson MJ; Svaasand LO; Nelson JS Lasers Surg Med; 2004; 34(5):407-13. PubMed ID: 15216534 [TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy of newly implanted glioma cells in the rat brain. Madsen SJ; Angell-Petersen E; Spetalen S; Carper SW; Ziegler SA; Hirschberg H Lasers Surg Med; 2006 Jun; 38(5):540-8. PubMed ID: 16392143 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]